Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 1763060.
- Also identified by PMC identifier 53155.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The results obtained in this study establish that liposome formulations incorporating a synthetic polyethylene glycol-derivatized phospholipid have a pronounced effect on liposome tissue distribution and can produce a large increase in the pharmacological efficacy of encapsulated antitumor drugs. This effect is substantially greater than that observed previously with conventional liposomes and is associated with a more than 5-fold prolongation of liposome circulation time in blood, a marked decrease in uptake by tissues such as liver and spleen, and a corresponding increased accumulation in implanted tumors. These and other properties described here have expanded considerably the prospects of liposomes as an effective carrier system for a variety of pharmacologically active macromolecules.
Medical subject headings
- Colonic Neoplasms
- Doxorubicin
- Epirubicin
- Liposomes
- Lymphoma